Government urged to grease R&D investment wheels

Published: 2003-03-06 07:00:00

Updated: 2003-03-06 07:00:00

Business sources say that to better enhance R&D capability in the domestic pharmaceutical industry, the current reimbursement price criteria needs to be readjusted in a manner such that new R&D fund including the intrinsic value of a product and manufacturer's endeavors should be well reflected i...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK